Abstract
Exposure of rat liver epithelial cells to doxorubicin, an anthraquinone derivative widely employed in cancer chemotherapy, led to a dose-dependent decrease in gap junctional intercellular communication (GJC). Gap junctions are clusters of inter-cellular channels consisting of connexins, the major connexin in the cells used being connexin-43 (Cx43). Doxorubicin-induced loss of GJC was mediated by activation of extracellular signal-regulated kinase (ERK)-1 and ERK-2, as demonstrated using inhibitors of ERK activation. Furthermore, activation of the epidermal growth factor (EGF) receptor by doxorubicin was responsible for ERK activation and the subsequent attenuation of GJC. Inhibition of GJC, however, was not by direct phosphorylation of Cx43 by ERK-1/2, whereas menadione, a 1,4-naphthoquinone derivative that was previously demonstrated to activate the same EGF receptor-dependent pathway as doxorubicin, resulting in downregulation of GJC, caused strong phos-phorylation of Cx43 at serines 279 and 282. Thus, ERK-dependent downregulation of GJC upon exposure to quinones may occur both by direct phosphorylation of Cx43 and in a phosphorylation-independent manner.
References
Abdelmohsen, K., Gerber, P.A., von Montfort, C., Sies, H., and Klotz, L.O. (2003). Epidermal growth factor receptor is a common mediator of quinone-induced signaling leading to phosphorylation of connexin-43: role of glutathione and tyrosine phosphatases. J. Biol. Chem.278, 38360–38367.10.1074/jbc.M306785200Search in Google Scholar
Abdelmohsen, K., Patak, P., von Montfort, C., Melchheier, I., Sies, H., and Klotz, L.O. (2004). Signaling effects of menadione: from tyrosine phosphatase inactivation to connexin phosphorylation. Methods Enzymol.378, 258–272.10.1016/S0076-6879(04)78020-9Search in Google Scholar
Brunmark, A. and Cadenas, E. (1989). Redox and addition chemistry of quinoid compounds and its biological implications. Free Radic. Biol. Med.7, 435–477.10.1016/0891-5849(89)90126-3Search in Google Scholar
Cameron, S.J., Malik, S., Akaike, M., Lerner-Marmarosh, N., Yan, C., Lee, J.D., Abe, J., and Yang, J. (2003). Regulation of epidermal growth factor-induced connexin 43 gap junction communication by big mitogen-activated protein kinase1/ERK5 but not ERK1/2 kinase activation. J. Biol. Chem.278, 18682–18688.10.1074/jbc.M213283200Search in Google Scholar
Carystinos, G.D., Alaoui-Jamali, M.A., Phipps, J., Yen, L., and Batist, G. (2001). Upregulation of gap junctional intercellular communication and connexin 43 expression by cyclic-AMP and all-trans-retinoic acid is associated with glutathione depletion and chemosensitivity in neuroblastoma cells. Cancer Chemother. Pharmacol.47, 126–132.10.1007/s002800000231Search in Google Scholar
Chabner, B.A., Ryan, D.P., Paz-Ares, L., Garcia-Carbonero, R., and Calabresi, P. (2001). Antineoplastic agents. In: The Pharmacological Basis of Therapeutics, J.G. Hardman, L.E. Limbird, and A.G. Gilman, eds. (New York, USA: McGraw-Hill), pp. 1389–1459.Search in Google Scholar
Coleman, W.B., McCullough, K.D., Esch, G.L., Faris, R.A., Hixson, D.C., Smith, G.J., and Grisham, J.W. (1997). Evaluation of the differentiation potential of WB-F344 rat liver epithelial stem-like cells in vivo. Differentiation to hepatocytes after transplantation into dipeptidylpeptidase-IV-deficient rat liver. Am. J. Pathol.151, 353–359.Search in Google Scholar
Fernstrom, M.J., Koffler, L.D., Abou-Rjaily, G., Boucher, P.D., Shewach, D.S., and Ruch, R.J. (2002). Neoplastic reversal of human ovarian carcinoma cells transfected with connexin43. Exp. Mol. Pathol.73, 54–60.10.1006/exmp.2002.2436Search in Google Scholar
Gewirtz, D.A. (1999). A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol.57, 727–741.10.1016/S0006-2952(98)00307-4Search in Google Scholar
Guise, S., Braguer, D., Carles, G., Delacourte, A., and Briand, C. (2001). Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells. J. Neurosci. Res.63, 257–267.10.1002/1097-4547(20010201)63:3<257::AID-JNR1019>3.0.CO;2-TSearch in Google Scholar
Huang, R.P., Hossain, M.Z., Huang, R., Gano, J., Fan, Y., and Boynton, A.L. (2001). Connexin 43 (cx43) enhances chemotherapy-induced apoptosis in human glioblastoma cells. Int. J. Cancer92, 130–138.10.1002/1097-0215(200102)9999:9999<::AID-IJC1165>3.0.CO;2-GSearch in Google Scholar
Klotz, L.O., Patak, P., Ale-Agha, N., Buchczyk, D.P., Abdelmohsen, K., Gerber, P.A., von Montfort, C., and Sies, H. (2002). 2-Methyl-1,4-naphthoquinone, vitamin K3, decreases gap-junctional intercellular communication via activation of the epidermal growth factor receptor/extracellular signal-regulated kinase cascade. Cancer Res.62, 4922–4928.Search in Google Scholar
Knebel, A., Böhmer, F.D., and Herrlich, P. (2000). Radiation-induced signal transduction. Methods Enzymol.319, 255–272.10.1016/S0076-6879(00)19026-3Search in Google Scholar
Kotamraju, S., Kalivendi, S.V., Konorev, E., Chitambar, C.R., Joseph, J., and Kalyanaraman, B. (2004). Oxidant-induced iron signaling in Doxorubicin-mediated apoptosis. Methods Enzymol.378, 362–382.10.1016/S0076-6879(04)78026-XSearch in Google Scholar
Lampe, P.D. and Lau, A.F. (2004). The effects of connexin phosphorylation on gap junctional communication. Int. J. Biochem. Cell Biol.36, 1171–1186.10.1016/S1357-2725(03)00264-4Search in Google Scholar
Leithe, E. and Rivedal, E. (2004). Epidermal growth factor regulates ubiquitination, internalization and proteasome-dependent degradation of connexin43. J. Cell Sci.117, 1211–1220.10.1242/jcs.00951Search in Google Scholar
Leykauf, K., Durst, M., and Alonso, A. (2003). Phosphorylation and subcellular distribution of connexin43 in normal and stressed cells. Cell Tissue Res.311, 23–30.10.1007/s00441-002-0645-5Search in Google Scholar
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., and Gianni, L. (2004a). Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol. Rev.56, 185–229.10.1124/pr.56.2.6Search in Google Scholar
Minotti, G., Recalcati, S., Menna, P., Salvatorelli, E., Corna, G., and Cairo, G. (2004b). Doxorubicin cardiotoxicity and the control of iron metabolism: quinone-dependent and independent mechanisms. Methods Enzymol.378, 340–361.10.1016/S0076-6879(04)78025-8Search in Google Scholar
Quiles, J.L., Huertas, J.R., Battino, M., Mataix, J., and Ramírez-Tortosa, M.C. (2002). Antioxidant nutrients and adriamycin toxicity. Toxicology180, 79–95.10.1016/S0300-483X(02)00383-9Search in Google Scholar
Tanaka, M. and Grossman, H.B. (2004). Connexin 26 induces growth suppression, apoptosis and increased efficacy of doxorubicin in prostate cancer cells. Oncol. Rep.11, 537–541.10.3892/or.11.2.537Search in Google Scholar
Trosko, J.E. and Ruch, R.J. (1998). Cell-cell communication in carcinogenesis. Front. Biosci.3, D208–D236.10.2741/A275Search in Google Scholar
Tsao, M.S., Smith, J.D., Nelson, K.G., and Grisham, J.W. (1984). A diploid epithelial cell line from normal adult rat liver with phenotypic properties of ‘oval’ cells. Exp. Cell Res.154, 38–52.10.1016/0014-4827(84)90666-9Search in Google Scholar
Warn-Cramer, B.J., Lampe, P.D., Kurata, W.E., Kanemitsu, M.Y., Loo, L.W., Eckhart, W., and Lau, A.F. (1996). Characterization of the mitogen-activated protein kinase phosphorylation sites on the connexin-43 gap junction protein. J. Biol. Chem.271, 3779–3786.10.1074/jbc.271.7.3779Search in Google Scholar PubMed
Willecke, K., Eiberger, J., Degen, J., Eckardt, D., Romualdi, A., Guldenagel, M., Deutsch, U., and Söhl, G. (2002). Structural and functional diversity of connexin genes in the mouse and human genome. Biol. Chem.383, 725–737.10.1515/BC.2002.076Search in Google Scholar PubMed
Zheng, J.H., Chen, C.T., Au, J.L., and Wientjes, M.G. (2001). Time- and concentration-dependent penetration of doxorubicin in prostate tumors. AAPS PharmSci.3, E15.10.1208/ps030215Search in Google Scholar PubMed PubMed Central
©2004 by Walter de Gruyter Berlin New York
